Wave of the new covid variants: vaccinations against infection urgently needed!

Wave of the new covid variants: vaccinations against infection urgently needed!

Gaithersburg, Md., U.S. - The European Commission on October 8, 2024 approved the updated Covid 19 vaccine Nuvaxovid ™ from Novavax for the 2024-2025 href = "https://ir.novavax.com/press-releases/2024-09-novaxs-update-2024-2025-nuvaxovid-tm-covid-19-Vaccine-receives-authorization-in-the-eu.com reported. This vaccine is specifically against the JN.1 variants, but also includes protection against their sub-variants, such as KP.2.3 and KP.3. Clinical studies showed that the most common side effects such as headaches, nausea and tiredness can occur among the vaccinated people. Compared to the MRNA vaccine from Biontech/Pfizer, which is also available, the effectiveness of the Novavax vaccine is classified as "almost the same" and will be available free of charge in medical practices and public vaccination centers from mid-December.

The Ministry of Health emphasizes the need for a refreshing vaccination, especially during the upcoming public holidays, where تجمعات and travel could increase the risk of infection. Current data in sewage monitoring shows that the covid infections have initially declined, but are now increasing again. The molecular biologist Ulrich Elling found that this trend continues after the autumn holidays as expected. The vaccination recommendation not only applies to the Novavax vaccine graduates, but also to everyone who has no refresh or infection. Vaccination could help reduce the risk of Long Covid and reduce the risk of infection.

Important information about the vaccines

The new Novavax vaccine comes as a protein-based variant with the Matrix-M ™ adjuvan, which reinforces the immune response. This vaccine formula is approved in the United States under an emergency permit for people aged 12 and over. As Kleinezeitung.at shows the current development that the contagisions are increasing again, which underlines the urgency of vaccination. The simultaneous administration against Covid and influenza is considered medically sensible in order to minimize the increased risk of severe disease courses during this season.